HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 86 filers reported holding HARPOON THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $80,989 | -34.2% | 111,601 | -11.8% | 0.00% | – |
| Q3 2022 | $123,000 | -69.2% | 126,570 | -39.4% | 0.00% | – |
| Q2 2022 | $399,000 | -50.3% | 208,920 | +29.3% | 0.00% | – |
| Q1 2022 | $803,000 | -5.2% | 161,567 | +44.1% | 0.00% | – |
| Q4 2021 | $847,000 | +22.8% | 112,100 | +28.3% | 0.00% | – |
| Q3 2021 | $690,000 | -77.7% | 87,398 | -60.8% | 0.00% | -100.0% |
| Q2 2021 | $3,094,000 | +234.5% | 223,039 | +404.6% | 0.00% | – |
| Q1 2021 | $925,000 | +71.9% | 44,203 | +36.4% | 0.00% | – |
| Q4 2020 | $538,000 | -3.9% | 32,418 | -1.7% | 0.00% | – |
| Q3 2020 | $560,000 | -39.4% | 32,983 | -40.7% | 0.00% | – |
| Q2 2020 | $924,000 | +463.4% | 55,630 | +403.2% | 0.00% | – |
| Q4 2019 | $164,000 | -44.0% | 11,055 | -48.5% | 0.00% | – |
| Q3 2019 | $293,000 | +5.4% | 21,450 | -26.9% | 0.00% | – |
| Q1 2019 | $278,000 | – | 29,356 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 4,524,425 | $66,916,000 | 29.45% |
| MPM BioImpact LLC | 3,898,422 | $57,658,000 | 20.43% |
| New Leaf Venture Partners, L.L.C. | 2,921,405 | $43,208,000 | 9.39% |
| Soleus Capital Management, L.P. | 123,200 | $1,822,000 | 1.76% |
| EcoR1 Capital, LLC | 908,547 | $13,437,000 | 1.21% |
| Orbimed Advisors | 2,446,409 | $36,182,000 | 0.52% |
| Artal Group S.A. | 850,000 | $12,572,000 | 0.49% |
| SPHERA FUNDS MANAGEMENT LTD. | 384,031 | $5,680,000 | 0.47% |
| Cormorant Asset Management, LP | 649,994 | $9,613,000 | 0.38% |
| Fosun International Ltd | 190,483 | $2,817,000 | 0.23% |